Tag: Drug Manufacturing

Advanced Pharma launched production of finished medicinal products in Belgorod

The enterprise was opened as part of implementing the investment project on establishing production of finished medicinal products with a design capacity of 100 tons of granules, 500 million capsules and coated tablets a year.

Ardena buys a leading contract manufacturer of APIs

Contract development and manufacturing organisation (CDMO) Ardena, headquartered in Belgium, has acquired ChemConnection, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines.

Boehringer Ingelheim will invest €40 million into its facility in Greece

The German pharmaceutical company Boehringer Ingelheim is expected to launch in the next few months a €40 million overhaul project in its production plant in Koropi, Greece.

Saneca Pharma renews its cooperation with Pharmascience

Saneca Pharma has renewed an agreement with Pharmascience Inc, one of Canada’s largest pharmaceutical companies, for the manufacture and supply of prescription medicines in tablet form.

Pre-commissioning activities were completed at Aspectus Pharma facility

The production facility prepares to undergo a GMP audit and obtain licenses for full-cycle manufacturing of modern, high-quality and safe drugs.

Russian Ministry amends procedure for licensing the manufacturing of drugs

drug manufacturing
The relevant order was elaborated to improve the quality of provision, period and availability of results of this public service, create comfortable conditions in relations arising during the provision of service.

Pfizer CentreOne launches its Enviero progesterone

Enviero progesterone is produced by a first-of-its-kind progesterone synthesis developed by Pfizer that reduces waste, greenhouse gas emissions and use of hazardous solvents.

Ministry will extend range of acquired goods from Kazakhstani manufacturers

The single distributor will extend the range of medicines acquired from Kazakhstani pharmaceutical companies, reports the Health Ministry of Kazakhstan.

FAS will inspect large pharmaceutical companies once in 5 years

The Russian Government signed a Decree that approved the criteria for assigning specific risk categories to legal entities and individual entrepreneurs.

MSD and AKRIKHIN localized manufacturing of sitagliptin in Russia

MSD, an innovative global pharmaceutical company, and AKRIKHIN, a leading Russian pharmaceutical manufacturer, announced the successful localization of 100 mg finished dosage form of sitagliptin.

Janssen intends to manufacture bedaquiline at the Pharmstandard plant in Ufa

Janssen Pharmaceutica N.V., a part of Janssen Pharmaceutical Companies of Johnson & Johnson, signed a memorandum of intent with Pharmstandard JSC to manufacture and supply Sirturo®, a medicinal product.

Import substitution leads to growth of drug manufacturing in Russia

Drug Manufacturing
According to Rosstat, in 2017, the output of medicines was 12.3% higher than in 2016. The Russian Ministry of Industry and Trade said that output growth was facilitated by state support to Russian manufacturers.

Approximately 8% of medications in Armenia are manufactured locally

Nearly 8% of medications in Armenia are locally produced, while the remaining is imported. Armenian-made drugs are exported to Moldova, Russia, Belarus, Tajikistan, Uzbekistan, Kazakhstan and Georgia.

Kalbe Farma launched its first biotech manufacturing facility in Indonesia

kalbe farma
Kalbe Farma, an Indonesian pharmaceutical company, has launched its first biotechnology-based drug factory at Cikarang, Indonesia, what has been hailed as a milestone in the industry.

Astellas will set up a drug manufacturing in Turkey

Japanese pharmaceutical company Astellas has decided to manufacture medications in Gebze, Turkey. In the first stage, contract manufacturing will be discussed for the production of medication for urinary tract ailments.

Hookipa Biotech entered in a GMP manufacturing collaboration with ABL Europe

test tubes
Hookipa Biotech AG, a clinical stage biotech company, and ABL Europe SAS, an ABL Inc. company providing viral vector GMP contract manufacturing services, have entered in a manufacturing collaboration.